Publications in collaboration with researchers from University of Melbourne (6)

2023

  1. Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

    Nature Reviews Clinical Oncology, Vol. 20, Núm. 6, pp. 372-389

2022

  1. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer

    New England Journal of Medicine, Vol. 387, Núm. 3, pp. 217-226

2021

  1. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

    npj Breast Cancer, Vol. 7, Núm. 1

2020

  1. Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

    Annals of Oncology, Vol. 31, Núm. 5, pp. 569-581

2017

  1. Research needs in breast cancer

    Annals of Oncology, Vol. 28, Núm. 2, pp. 208-217

  2. Tumor-infiltrating lymphocytes in Breast Cancer and implications for clinical practice

    Biochimica et Biophysica Acta - Reviews on Cancer, Vol. 1868, Núm. 2, pp. 527-537